Shelley Leighton

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
6606 Background: Over the last decade, BCR-ABL inhibitors have improved clinical prognoses of pts with CML. Few studies have evaluated attributes related to CML disease and treatment and their impact on pt management in a real-world setting. This study aims to understand the impact of CML disease and treatment on quality of life (QoL), treatment adherence,(More)
OBJECTIVE To determine use of breast cancer screening and barriers to screening among women in First Nations communities (FNCs). DESIGN Structured, administered survey. SETTING Five FNCs in New Brunswick. PARTICIPANTS One hundred thirty-three (96%) of 138 eligible women between the ages of 50 and 69 years. INTERVENTIONS After project objectives,(More)
  • 1